 |
|
Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung, Jai Won Chang
Clin Mol Hepatol. 2023;29(4):891-908. Published online 2023 Apr 13 DOI: https://doi.org/10.3350/cmh.2023.0024
|
|
Citations to this article as recorded by
 VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis
Shohei Asada, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Takahiro Kubo, Takemi Akahane, Hideto Kawaratani, Norihisa Nishimura, Soichi Takeda, Hiroyuki Masuda, Akihiko Shibamoto, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, Yuki Tsuji, Yukihisa Fujin
Digestive Diseases and Sciences.2024; 69(3): 851. CrossRef Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina
International Journal of Molecular Sciences.2024; 25(4): 1988. CrossRef Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
Xingyue Huang, Jas Bindra, Ishveen Chopra, John Niewoehner, George J. Wan
Advances in Therapy.2023; 40(12): 5432. CrossRef
|